Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-30 @ 12:29 AM
Study NCT ID:
NCT07385703
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-02-04
First Post:
2026-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.
Sponsor:
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-05
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-25
First Submit QC Date:
None
Study First Post Date:
2026-02-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-03
Last Update Post Date:
2026-02-04
Last Update Post Date Type:
ACTUAL